AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients-Reference-Cited by-同舟云学术

AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients

Published:2014-02 Issue:5 Volume:63 Page:430-433
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Desai Nihar R.,Giugliano Robert P.,Zhou Jing,Kohli Payal,Somaratne Ransi,Hoffman Elaine,Liu Thomas,Scott Robert,Wasserman Scott M.,Sabatine Marc S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines;Grundy;J Am Coll Cardiol,2004

2. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999–2006;Kuklina;JAMA,2009

3. Achieving optimal lipid goals in patients with coronary artery disease;Karalis;Am J Cardiol,2011

4. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

5. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT–TIMI 22 substudy;Wiviott;J Am Coll Cardiol,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-hospital initiation of a PCSK9 inhibitor in patients with acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials;Medicine;2024-03-08

2. Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China;The Journal of Clinical Endocrinology & Metabolism;2024-03-04

3. Association of low-density lipoprotein-cholesterol with all-cause and cause-specific mortality;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-06

4. PCSK9 and LRP6: potential combination targets to prevent and reduce atherosclerosis;Journal of Basic and Clinical Physiology and Pharmacology;2022-04-18

5. Efectividad y seguridad del tratamiento con iPCSK9 en vida real: experiencia de tres hospitales asturianos;Medicina de Familia. SEMERGEN;2021-09